Coloplast announced it will acquire wound care product company Kerecis for $1.3 billion. The acquisition will give Coloplast an opportunity to “strategically strengthen [its] presence in the advanced ...

Coloplast is the market leader with an estimated 38% share; privately held competitors Hollister and ConvaTec roughly split the rest of the market. Although the ostomy market only grows in the ...

Coloplast saw fiscal third-quarter organic growth of 7%, but reported growth declined 1% thanks to the divestiture of the skin care business and unfavorable foreign exchange. Quarterly adjusted ...

Coloplast (CLPBY) faces operational challenges, with four consecutive top-line misses and reduced growth expectations, but retains a strong core franchise. CLPBY's CEO search remains unresolved, and ...